Neural Stem Cell-Mediated Delivery of Irinotecan-Activating Carboxylesterases to Glioma: Implications for Clinical Use
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neural Stem Cell-Mediated Delivery of Irinotecan-Activating Carboxylesterases to Glioma: Implications for Clinical Use
Authors
Keywords
-
Journal
Stem Cells Translational Medicine
Volume 2, Issue 12, Pages 983-992
Publisher
Wiley
Online
2013-10-29
DOI
10.5966/sctm.2012-0177
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neural Stem Cell-Mediated Enzyme/Prodrug Therapy for Glioma: Preclinical Studies
- (2013) K. S. Aboody et al. Science Translational Medicine
- Stem cell-based therapy for malignant glioma
- (2012) Daniel Bexell et al. CANCER TREATMENT REVIEWS
- Neural stem cell-mediated CE/CPT-11 enzyme/prodrug therapy in transgenic mouse model of intracerebellar medulloblastoma
- (2012) M Gutova et al. GENE THERAPY
- Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging
- (2012) Mya S Thu et al. NATURE MEDICINE
- Genetically engineered human neural stem cells with rabbit carboxyl esterase can target brain metastasis from breast cancer
- (2011) Ho Jun Seol et al. CANCER LETTERS
- Targeted Drug Delivery Using Immunoconjugates
- (2011) Maria Valentina Pasquetto et al. JOURNAL OF IMMUNOTHERAPY
- Neural Stem Cell-based Cell Carriers Enhance Therapeutic Efficacy of an Oncolytic Adenovirus in an Orthotopic Mouse Model of Human Glioblastoma
- (2011) Atique U Ahmed et al. MOLECULAR THERAPY
- Human Neural Stem Cell Tropism to Metastatic Breast Cancer
- (2011) Donghong Zhao et al. STEM CELLS
- Organ-specific carboxylesterase profiling identifies the small intestine and kidney as major contributors of activation of the anticancer prodrug CPT-11
- (2010) M. Jason Hatfield et al. BIOCHEMICAL PHARMACOLOGY
- Translational research in brain metastasis is identifying molecular pathways that may lead to the development of new therapeutic strategies
- (2010) Brunilde Gril et al. EUROPEAN JOURNAL OF CANCER
- New flow cytometric assays for monitoring cell-mediated cytotoxicity
- (2010) Liubov Zaritskaya et al. Expert Review of Vaccines
- Recognition and Killing of Brain Tumor Stem-Like Initiating Cells by CD8+ Cytolytic T Cells
- (2009) C. E. Brown et al. CANCER RESEARCH
- Intracellular dynamics of topoisomerase I inhibitor, CPT-11, by slit-scanning confocal Raman microscopy
- (2009) Yoshinori Harada et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Novel drug delivery strategies in neuro-oncology
- (2009) Dani S. Bidros et al. Neurotherapeutics
- Iron Labeling and Pre-Clinical MRI Visualization of Therapeutic Human Neural Stem Cells in a Murine Glioma Model
- (2009) Mya S. Thu et al. PLoS One
- An improved human carboxylesterase for enzyme/prodrug therapy with CPT-11
- (2008) M Wierdl et al. CANCER GENE THERAPY
- Stem and progenitor cell-mediated tumor selective gene therapy
- (2008) K S Aboody et al. GENE THERAPY
- Neural Stem Cell Tropism to Glioma: Critical Role of Tumor Hypoxia
- (2008) D. Zhao et al. MOLECULAR CANCER RESEARCH
- Malignant Gliomas in Adults
- (2008) Patrick Y. Wen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Urokinase Plasminogen Activator and Urokinase Plasminogen Activator Receptor Mediate Human Stem Cell Tropism to Malignant Solid Tumors
- (2008) Margarita Gutova et al. STEM CELLS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search